Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Katarina Zanchetta"'
Autor:
Patrik Palacka, Monika Polanova, Alena Svobodova, Jan Zigmond, Katarina Zanchetta, Vlasta Gombarova, Martina Vulganova, Jan Slopovsky, Jana Obertova, Michal Mego, Lubos Drgona, Juraj Pechan
Publikováno v:
Journal of Clinical Oncology. 40:e18774-e18774
e18774 Background: Vaccination remains the leading strategy against Covid-19 worldwide. BNT 162b2 (tozinameran) belongs among first licensed vaccines with good efficacy. However, the role of monitoring both, antibodies and cell immunity after vaccina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2805e540abc4f22c2b0d1a2a3fcd03e7
https://doi.org/10.1200/jco.2022.40.16_suppl.e18774
https://doi.org/10.1200/jco.2022.40.16_suppl.e18774
Autor:
Michal Mego, Katarina Zanchetta, Juraj Pechan, Vladimira Baranova, Jan Slopovsky, Beata Bernadicova, Eva Badurikova, Lubos Drgona, Patrik Palacka
Publikováno v:
Journal of Clinical Oncology. 39:e18724-e18724
e18724 Background: Active immunization seems to be the most effective protection against COVID-19. The objective of this prospective study was to explore the side effects of mRNA vaccine Tozinameran and possible differences in their incidence between
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a494efd34e833f38dca7436b7327f399
https://doi.org/10.1200/jco.2021.39.15_suppl.e18724
https://doi.org/10.1200/jco.2021.39.15_suppl.e18724